Published Date : Mar 07, 2016
Albany, New York, March 07, 2016 - MarketResearchReports.biz has added a new research report, titled “Fertility Market In The US 2016-2020,” to its vast repository. The research report on the fertility market in the U.S. explains the historical data and compares it with the current market situation to map a trajectory for the market for the coming few years. For an accurate reports, the research report has implemented SWOT reports and Porter’s five forces reports. The former explains the strengths, weaknesses, opportunities, and threats, while the latter brings in a perspective on the threat of new entrants, the threat of substitute products or services, the bargaining power of customers, the bargaining power of suppliers, and the intensity of competitive rivalry in the market.
The research report suggests that the fertility services market in the U.S. is expected to register a CAGR of 4.07% during the period from 2016 to 2020. This growth is attributable to the growing fertility problems amongst men as well as women in the region. Fertility issues amongst couples are defined as the inability to conceive despite unprotected coitus over a period of six months amongst couples where the woman’s age is 35 or more. Infertility amongst men and women forms one-third of the cases that contribute towards the growth of the fertility market in the U.S. In the remainder of the cases, the causes are either unknown or the inability to conceive is the result of a combination of factors in both men and women.
The causes of infertility in men can be related to abnormal sperm function, low sperm production, or blockages that prevent sperm delivery. In women, infertility is attributable to hormonal changes, damage to the fallopian tube, cervical abnormalities, and endometriosis. Nailing the cause of infertility in people is extremely difficult. However, the fertility market offers a wide range of solutions to patients depending on their issues. The U.S. fertility drugs market is segmented on the basis of treatment into infertility drugs and assisted reproductive technology (ART).
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/560799
The research report on the U.S. fertility market points out that the emergence of assisted reproductive technology and acceptance of same-sex marriages will drive this market in the coming years. Strategic mergers and acquisitions in the U.S. fertility market will be a significant trend in the coming few years. However, the U.S. fertility market will be hampered by the exorbitant cost of the fertility treatment.
Some of the key players in the U.S. fertility market are Ferring Pharmaceuticals, CooperSurgical, Cellcura, Intramed, and Merck. The research report offers a complete explanation of the competitive landscape of the U.S. fertility market and gives an understanding of the regulatory framework impacting the market. Furthermore, it also explains the financial overview, research and development activities, business and marketing strategies, product portfolio, and investment outlook of these top players in the U.S. fertility market.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com